Literature DB >> 8432563

Direct and indirect effects of E. coli lipopolysaccharide on isolated human polymorphonuclear granulocytes and mixed leukocytes.

H Opdahl1.   

Abstract

Polymorphonuclear neutrophil granulocytes (PMN) may contribute to the lung injury induced by nonpulmonary infections with gram-negative bacteria. The direct effect of E. coli lipopolysaccharide (LPS) on isolated human PMN or mixed leukocytes (ML), as well as the priming effect of preincubating cells with LPS, was examined in assays measuring the maximal rate of oxygen consumption (OC), cell chemiluminescence (CHML), and aggregation (AGG). LPS, 1-10 micrograms/ml, caused no acute response in PMN or ML suspended in Fisher's-HEPES medium with BSA (FHA), but increased both CHML and AGG of cells suspended in autologous plasma. Preincubation in FHA with LPS, 1 microgram/ml, for more than 15 min increased the OC of PMN activated with zymosan-activated plasma (ZAP) or n-formyl-methionyl-leu-cyl-phenylalanine (FMLP) by more than 100%. A similar increase in the CHML of such cells was seen after FMLP, but not after ZAP. ZAP, however, primed the CHML response of the cells to subsequent activation with FMLP more than did preincubation with LPS. Previous exposure to both agents had an additive effect. Preincubation of PMN with LPS decreased the time interval from addition of phorbol myristate acetate (PMA) to peak OC response, but less so than previous activation with FMLP. Neither agent affected the maximal rate of OC after addition of PMA. LPS also increased the PMN aggregation induced by ZAP and FMLP, but not by PMA. Cells preincubated with LPS, 0.01 microgram/ml, increased their CHML in response to FMLP if suspended in Krebs-Ringer balanced salt solution, but not if suspended in FHA. Such preincubation had no effect on OC of similarly activated cells in any of the media.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8432563     DOI: 10.1007/bf00916392

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  45 in total

1.  Gamma interferon is able to enhance the oxidative metabolism of human neutrophils.

Authors:  G Berton; L Zeni; M A Cassatella; F Rossi
Journal:  Biochem Biophys Res Commun       Date:  1986-08-14       Impact factor: 3.575

2.  Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions.

Authors:  J C Fantone; P A Ward
Journal:  Am J Pathol       Date:  1982-06       Impact factor: 4.307

3.  Human GM-CSF primes neutrophils for enhanced oxidative metabolism in response to the major physiological chemoattractants.

Authors:  R H Weisbart; L Kwan; D W Golde; J C Gasson
Journal:  Blood       Date:  1987-01       Impact factor: 22.113

4.  Modulation of neutrophil oxidative responses to soluble stimuli by platelet-activating factor.

Authors:  J C Gay; J K Beckman; K A Zaboy; J N Lukens
Journal:  Blood       Date:  1986-04       Impact factor: 22.113

5.  The modification of biophysical and endotoxic properties of bacterial lipopolysaccharides by serum.

Authors:  R J Ulevitch; A R Johnston
Journal:  J Clin Invest       Date:  1978-12       Impact factor: 14.808

6.  Antiinflammatory effects of endotoxin. Inhibition of rabbit polymorphonuclear leukocyte responses to complement (C5)-derived peptides in vivo and in vitro.

Authors:  J T Rosenbaum; K T Hartiala; R O Webster; E L Howes; I M Goldstein
Journal:  Am J Pathol       Date:  1983-12       Impact factor: 4.307

7.  An endothelial cell surface factor(s) induced in vitro by lipopolysaccharide, interleukin 1, and tumor necrosis factor-alpha increases neutrophil adherence by a CDw18-dependent mechanism.

Authors:  T H Pohlman; K A Stanness; P G Beatty; H D Ochs; J M Harlan
Journal:  J Immunol       Date:  1986-06-15       Impact factor: 5.422

8.  Acute effects of Escherichia coli endotoxin on the pulmonary microcirculation of anesthetized sheep structure:function relationships.

Authors:  B Meyrick; K L Brigham
Journal:  Lab Invest       Date:  1983-04       Impact factor: 5.662

9.  Quantification of the terminal complement complex in human plasma by an enzyme-linked immunosorbent assay based on monoclonal antibodies against a neoantigen of the complex.

Authors:  T E Mollnes; T Lea; S S Frøland; M Harboe
Journal:  Scand J Immunol       Date:  1985-08       Impact factor: 3.487

10.  Priming of neutrophils for enhanced release of oxygen metabolites by bacterial lipopolysaccharide. Evidence for increased activity of the superoxide-producing enzyme.

Authors:  L A Guthrie; L C McPhail; P M Henson; R B Johnston
Journal:  J Exp Med       Date:  1984-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.